A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Endostatin is a potent endogenous angiogenic inhibitor with implicated antitumor activity. However, efficacy of recombinant human endostatin (rhES) in clinical trials is controversial, and application of rhES in treatment of metastatic melanoma awaits further investigations. This phase II trial eval...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cui, Chuanliang, Mao, Lili, Chi, Zhihong, Si, Lu, Sheng, Xinan, Kong, Yan, Li, Siming, Lian, Bin, Gu, Kangsheng, Tao, Min, Song, Xin, Lin, Tongyu, Ren, Xiubao, Qin, Shukui, Guo, Jun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3702105/
https://ncbi.nlm.nih.gov/pubmed/23670576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2013.79
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller